A Phase I, Two-Part, Randomised, Open, Single-Centre, Crossover Study to Evaluate Different Extended-Release Formulations of AZD1305 When Given as Single Oral Doses to Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2010
At a glance
- Drugs AZD 1305 (Primary)
- Indications Arrhythmias
- Focus Pharmacokinetics
- 02 Dec 2010 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 23 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jun 2008 New trial record.